Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Posted on by Academic achievements

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Aydan Orscelik | Medicine – Saglik Bilimleri University, Turkey

Dr. Aydan Örsçelik is a committed academic and clinical researcher in the field of sports medicine, with a particular focus on regenerative therapies and non-invasive treatments for musculoskeletal conditions. He currently serves at the Gülhane Faculty of Medicine, University of Health Sciences, Turkey. Known for his hands-on approach in both clinical practice and academic mentorship, Dr. Örsçelik’s work bridges the gap between research and patient care. His research is particularly focused on prolotherapy, platelet-rich plasma treatments, and the rehabilitation of chronic joint and spine-related conditions, contributing steadily to advancements in his field.

Profile:

Orcid | Scopus | Google Scholar

Education:

Dr. Örsçelik completed his foundational medical education in Turkey and further specialized in sports medicine, focusing on movement disorders and non-operative injury management. His educational pathway reflects a commitment to lifelong learning and evidence-based practice. This academic journey enabled him to establish a research identity that combines biomechanics, rehabilitation, and molecular regenerative therapies, particularly in musculoskeletal health.

Experience:

Over the years, Dr. Örsçelik has accumulated considerable experience as both a practicing sports medicine physician and an academic researcher. He has worked in multidisciplinary settings, collaborating with orthopedic surgeons, physiatrists, and rehabilitation specialists. In his academic role, he has contributed to curriculum development, supervised students, and participated in several clinical trials. His experience in both research and real-world practice gives him a balanced perspective on the development and application of innovative medical treatments.

Research Interests:

Dr. Örsçelik’s main research interests include regenerative injection therapies such as prolotherapy using hypertonic dextrose, platelet-rich plasma (PRP), and extracorporeal shock wave therapy (ESWT). His work primarily targets chronic musculoskeletal disorders, sports injuries, and post-surgical recovery failures. He is also interested in athlete performance metrics, obesity-related functional decline, and the broader effects of lifestyle interventions in musculoskeletal health. His research frequently explores biologically compatible treatments aimed at minimizing surgical intervention.

Awards & Recognition:

While formal awards are not explicitly listed, Dr. Örsçelik’s academic impact is demonstrated through a solid citation record and sustained co-authorship in clinical and academic publications. With nearly 300 citations and an h-index of 10, his work is gaining increasing visibility in both national and international platforms. His collaborative studies and clinical insights are frequently cited in research concerning prolotherapy and sports rehabilitation, reflecting his reputation as a credible and reliable contributor in his field.

Selected Publications:

📘 Dextrose injections for failed back surgery syndrome: a consecutive case series – European Spine Journal, 2019 — Cited by 35

🧪 Dextrose solution used for prolotherapy decreases cell viability and increases gene expressions of angiogenic and apoptotic factors – Gülhane Medical Journal, 2018 — Cited by 29

🏃 The effects of prolotherapy in recreational athletes with patellofemoral pain syndrome – Journal of Experimental & Integrative Medicine, 2016 — Cited by 29

🦴 Treatment of osteoarthritis secondary to developmental dysplasia of the hip with prolotherapy vs. exercise control – Medical Science Monitor, 2020 — Cited by 19

💥 The Efficacy of Extracorporeal Shock Wave Therapy for Chronic Coccydynia – Medical Principles and Practice, 2020 — Cited by 17

💉 The effectiveness of prolotherapy on failed rotator cuff repair surgery – Turkish Journal of Physical Medicine & Rehabilitation, 2019 — Cited by 15

🧍 Is 5% dextrose prolotherapy effective for radicular low back pain? – Gülhane Tıp Dergisi, 2019 — Cited by 14

Conclusion:

Dr. Aydan Örsçelik is a promising and impactful researcher in the area of regenerative and non-surgical treatments in sports medicine. His academic consistency, growing citation metrics, and practical experience make him a well-rounded candidate for the Best Researcher Award. Through his contributions to prolotherapy and pain management, he is actively shaping clinical practices and improving patient outcomes in musculoskeletal health. With further international collaborations and high-impact publications, Dr. Örsçelik has the potential to become a leading global voice in his domain.

 

 

Stuart Maudsley | Pharmacology | Best Researcher Award

Posted on by Academic achievements

Prof. Dr. Stuart Maudsley | Pharmacology | Best Researcher Award

Prof. Dr. Stuart Maudsley | Pharmacology – Professor at Moffitt Cancer Center, United States

Dr. Stuart Russell Maudsley is an esteemed researcher and principal investigator whose work has had a profound impact on the field of pharmacology, particularly in the study of G-protein-coupled receptors (GPCRs). His career has been marked by significant contributions to cancer research, aging, and molecular gerontology, leading to the development of innovative therapeutic strategies aimed at treating complex human diseases. Dr. Maudsley’s work focuses on the precision targeting of GPCRs to develop treatments for a wide range of conditions, from cancer to neurodegenerative disorders, with a unique approach that blends basic science with clinical applications. He has been instrumental in leading transformative research at Moffitt Cancer Center and has earned widespread recognition for his contributions in both academia and industry.

Profile:

Scopus

Education:


Dr. Maudsley earned his Ph.D. in Pharmacology from the University of Leeds, UK, after completing a First-Class Bachelor’s degree in Pharmacology at the same institution. His doctoral research focused on electrophysiological and molecular biological studies of Tachykinin receptors, which set the stage for his continued exploration of receptor biology. His academic journey laid the groundwork for a career dedicated to uncovering the complex molecular mechanisms that regulate cellular behavior and how these processes can be manipulated for therapeutic purposes. His early education and research provided a foundation for his later innovations in the field of pharmacology and receptor therapeutics.

Experience:


Dr. Maudsley’s career spans several prestigious roles that highlight his leadership and expertise in pharmacology and receptor biology. He currently serves as the principal investigator at Moffitt Cancer Center, where he directs the Maudsley Lab, focusing on receptor biology and cancer therapeutics. His work is particularly notable for its precision in targeting GPCRs to treat cancer and other complex diseases. Dr. Maudsley also co-founded HeptOME – Receptor Therapeutics, and his position as a Special Science Advisor for the Belgian Superior Health Council reflects his international influence. His experience in both academic and industry settings has allowed him to bridge the gap between cutting-edge research and real-world therapeutic solutions.

Research Interests:


Dr. Maudsley’s primary research interest lies in the molecular and pharmacological study of GPCRs, a class of receptors that play a crucial role in various cellular processes. He focuses on understanding how these receptors regulate human diseases, particularly cancer, aging, and neurodegenerative disorders. By investigating the intricate mechanisms of GPCR signaling, Dr. Maudsley aims to develop novel targeted therapies that can improve treatment outcomes in these complex diseases. His research extends to systems pharmacology, which integrates multidimensional approaches to identify new drug targets and improve therapeutic strategies. Dr. Maudsley is particularly interested in the therapeutic application of GPCR-targeted medicines and their potential to treat diseases with unmet medical needs.

Awards:


Dr. Maudsley has received numerous accolades for his pioneering research in pharmacology and receptor biology. His work has been consistently recognized for its potential to revolutionize therapeutic strategies for cancer and aging-related diseases. He has been invited to speak at prestigious international conferences and has received several awards from scientific and medical societies for his contributions to understanding receptor biology. His recognition as a co-founder of HeptOME – Receptor Therapeutics further highlights his entrepreneurial spirit and ability to translate scientific discoveries into practical applications that benefit patients worldwide.

Publications:


Dr. Maudsley has an extensive publication record, contributing to major scientific journals and collaborative research projects. A few notable publications include:

  1. Maudsley S., Leysen H., van Gastel J., Martin B. (2021). Systems Pharmacology: Enabling Multidimensional Therapeutics, Reference Module in Biomedical Sciences. 📖
  2. Maudsley S., Schrauwen C., Harputluoğlu İ., Walter D., Leysen H., McDonald P. (2023). GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process, Int J Mol Sci. 🔬
  3. Schreurs G., Maudsley S., Nast C., Praet M., Da Silva Fernandes S., Boor P., D’Haese P., De Broe M.E., Vervaet B.A. (2023). Chronic Dehydration Induces Injury Pathways in Rats, Sci Rep. 🧪
  4. Maudsley S., Leysen H., Walter D., Vandoren R. (2023). GPCRs Regulate DNA Integrity, Encyclopedia – Biochemistry and Molecular Biology. 📑
  5. Coppens V., De Wachter O., Goossens J., Hendrix J., Maudsley S., Azmi A., van Gastel J., Van Saet A., Lauwers T., Morrens M. (2020). Profiling of Peripheral Blood Mononuclear Cells for Schizophrenia Biomarkers, Neuropsychobiology. 🧠
  6. Van Meenen J., Leysen H., Chen H., Baccarne R., Walter D., Martin B., Maudsley S. (2022). Making Biomedical Sciences Publications More Accessible for Machines, Med Health Care Philos. 💻
  7. Leysen H., Maudsley S., Van Gastel J., Martin B. (2021). The RXFP3 Receptor is a Modulator of Aging-Related Disease, Int J Mol Sci. 🧬

Conclusion:


Dr. Stuart Russell Maudsley’s extensive contributions to pharmacology, especially in the area of GPCRs and their role in complex diseases, make him an exceptional candidate for the Best Researcher Award. His research, which bridges the gap between basic science and clinical applications, continues to shape the future of precision medicine. Through his innovative work at Moffitt Cancer Center and his involvement in entrepreneurial ventures like HeptOME – Receptor Therapeutics, Dr. Maudsley has made a lasting impact on both academia and industry. His leadership in the field and his commitment to advancing therapeutic solutions for cancer, aging, and neurodegenerative diseases position him as a truly deserving nominee for this prestigious award.

Chien-Lung Hsu | Healthcare | Best Researcher Award

Posted on by Academic achievements

Prof. Chien-Lung Hsu | Healthcare | Best Researcher Award

Professor at Chang-Gung University (CGU), Taiwan.

Dr. Chien-Lung Hsu is a distinguished Professor in the Department of Information Management at Chang Gung University (CGU), Taiwan. Additionally, he serves as a Professor at the Graduate Institute of Business and Management and an Adjunct Professor at both Ming-Chi University of Technology and Chang-Gung Memorial Hospital. He received his Ph.D. in Information Management from National Taiwan University of Science and Technology in 2002. Dr. Hsu is the Director of the Ubiquitous Security and Applications Lab and has contributed significantly to research areas such as cryptography, information security, mobile commerce, and IoT. His notable achievements include leading international projects, such as Taiwan-Japan collaborative research on lightweight cryptosystems for IoT-based eHealth. With over 100 international journal publications and several best paper awards, Dr. Hsu is highly regarded in his field. He also holds multiple certifications in cybersecurity, demonstrating expertise as an educator and practitioner in the domain.

Profile Verification

Scopus 

Education

Dr. Chien-Lung Hsu holds a Ph.D. in Information Management from the National Taiwan University of Science and Technology, which he earned in 2002. He also completed an M.S. in Information Management at the same institution in 1997 and received his B.S. in Business Administration in 1995. Dr. Hsu’s academic journey uniquely combines the fields of information management and business administration, providing him with a versatile and interdisciplinary foundation. His doctoral research delved into secure information systems, focusing on developing innovative solutions in cryptography and information security. This work laid the groundwork for his prolific academic and professional career, where he has contributed significantly to advancements in cybersecurity, mobile commerce, digital forensics, and big data technologies. In addition to his studies, Dr. Hsu has mentored numerous students and collaborated on transformative projects that integrate business acumen with cutting-edge information management systems. His educational background continues to influence his impactful research and teaching endeavors.

Experience

Dr. Hsu’s career spans academia, research, and industry collaboration. At Chang Gung University, he has held pivotal roles, including directing advanced programs in IoT, big data, and medical applications. Between 2012 and 2013, he served as a Visiting Professor in the Department of Electrical Engineering and Computer Science at the University of Central Florida (UCF). Dr. Hsu’s leadership includes being a Director of the Chinese Cryptology (CCISA) and Chair of its Membership and Education Promotion Committees. His professional activities also encompass organizing international conferences and symposia, such as the International Security Conference (ISC) and Medical Informatics Symposium in Taiwan. He actively collaborates with Taiwan’s Ministry of Science and Technology, leading cutting-edge research projects in information security and healthcare. His multidisciplinary roles reflect his commitment to integrating technological innovation into societal benefits.

Research Interests

Dr. Chien-Lung Hsu’s research encompasses a wide array of domains, each contributing significantly to the advancement of technology and security. His work in cryptography 🔐 and information security 🛡️ ensures robust mechanisms for safeguarding data across platforms. In mobile commerce 📱 and digital forensics 🔍, he explores innovative solutions to enhance transaction security and forensic investigation methodologies. Dr. Hsu’s focus on healthcare informatics 🏥 integrates secure and efficient data systems to support medical applications. Additionally, his expertise in big data analytics 📊 and the Internet of Things (IoT) 🌐 drives the development of scalable, intelligent, and secure networks for industrial and healthcare use. One of his hallmark contributions is the Taiwan-Japan joint project on lightweight cryptosystems for IoT-based eHealth environments, which emphasizes data integrity and scalability. By adopting an interdisciplinary approach, Dr. Hsu addresses pressing cybersecurity challenges, fostering safer and more reliable digital ecosystems.

Awards and Honors

Dr. Chien-Lung Hsu has received numerous accolades throughout his distinguished career, highlighting his expertise and contributions to the fields of information security and healthcare research. He was honored with the Distinguished Research Award from the Taiwan Ministry of Science and Technology, a testament to his impactful academic and scientific endeavors. Dr. Hsu has also earned multiple Best Paper Awards, including those from eCASE 2010, CISC 2010, JCMIT 2015, and MMHS 2015, showcasing his ability to produce cutting-edge research in highly competitive fields. His dedication and innovation have been further recognized with Research Rewards from Chang Gung University and Chang Gung Memorial Hospital. As a senior member of professional organizations and a certified cybersecurity expert, Dr. Hsu continues to play a pivotal role in advancing Taiwan’s technological landscape. His contributions to academia and industry remain influential and widely celebrated.

Publications

A Hierarchical Blockchain System for Social Economy Services

Authors: Chin, Y.-C.; Hsu, C.-L.; Lin, T.-W.; Tsai, K.-Y.

Year: 2024

Citations: 0

Design and Evaluation of Device Authentication and Secure Communication System with PQC for AIoT Environments

Authors: Chen, Y.-J.; Hsu, C.-L.; Lin, T.-W.; Lee, J.-S.

Year: 2024

Citations: 0

Technological Empowerment for Aging Workforce in Elderly Care Programs: Service Model Design and Development of an Elderly Care Shared Service Platform

Authors: Tsai, T.-H.; Lo, H.-Y.; Wu, S.-L.; Chen, Y.-P.; Hsu, C.-L.

Year: 2024

Citations: 0

ID-Based Deniable Authentication Protocol with Key Agreement and Time-Bound Properties for 6G-Based WBAN Healthcare Environments

Authors: Hsu, C.-L.; Nguyen, A.-T.; Cheng, G.-L.

Year: 2023

Citations: 0

Developing the “Healthcare CEO App” for Patients with Type 1 Diabetes Transitioning from Adolescence to Young Adulthood: A Mixed-Methods Study

Authors: Chiang, Y.-T.; Chang, C.-W.; Yu, H.-Y.; An, C.; Moons, P.

Year: 2023

Citations: 2

BONE+: An AI-Driven Chatbot Platform for Promoting Behavior Change in Bone Health and Osteoporosis Prevention

Authors: Tsai, T.-H.; Hsieh, Y.-S.; Ho, C.-S.; Pei, Y.-C.; Hsu, C.-L.

Year: 2023

Citations: 0

Privacy-Preserved Hierarchical Authentication and Key Agreement for AI-Enabled Telemedicine Systems

Authors: Lin, T.-W.; Hsu, C.-L.

Year: 2023

Citations: 2

A Hybrid Blockchain-Based Log Management Scheme with Nonrepudiation for Smart Grids

Authors: Le, T.-V.; Hsu, C.-L.; Chen, W.-X.

Year: 2022

Citations: 18

Evaluating Digital Divide Based on Big Wireless Logs: A Case Study among Remote Tribes in Taiwan

Authors: Chen, S.-H.; Li, H.-C.; Liaw, Y.-C.; Le, T.-V.; Luo, W.-L.

Year: 2022

Citations: 2

A Novel Three-Factor Authentication Protocol for Multiple Service Providers in 6G-Aided Intelligent Healthcare Systems

Authors: Le, T.-V.; Lu, C.-F.; Hsu, C.-L.; Chou, Y.-F.; Wei, W.-C.

Year: 2022

Citations: 24

Conclusion

Dr. C.L. Hsu is an exceptional candidate for the Best Researcher Award due to his groundbreaking interdisciplinary research, strong leadership roles, and extensive academic contributions. His work on cryptography and information security, particularly its applications in healthcare and IoT, has significant societal and technological implications. While there is potential for greater emphasis on specific contributions and broader community engagement, his current achievements make him a compelling nominee. Recognizing Dr. Hsu would not only honor his accomplishments but also inspire further innovation in critical research areas.

 

Gulali Aktas | Medicine | Best Researcher Award

Posted on by Academic achievements

Prof Dr. Gulali Aktas | Medicine | Best Researcher Award

Academician | Abant Izzet Baysal University | Turkey

Short Bio 🌟

Gulali Aktas, born on July 16, 1975, is a distinguished academic in the Department of Internal Medicine at the Faculty of Medicine, Abant Izzet Baysal University, located in Golkoy, Bolu, Turkey. With a career dedicated to advancing medical science and improving patient care, Dr. Aktas has made significant contributions to the field of internal medicine. You can reach Dr. Aktas at draliaktas@yahoo.com or aliaktas@ibu.edu.tr, and connect on LinkedIn here.

Profile

ORCID

Education 🎓

Dr. Gulali Aktas completed his medical education with a focus on internal medicine. His rigorous academic training laid a strong foundation for his future research and clinical work, equipping him with the knowledge and skills necessary to excel in his field.

Experience 👨‍⚕️

With years of experience in internal medicine, Dr. Aktas has served at Abant Izzet Baysal University, where he has been involved in both clinical practice and academic teaching. His extensive experience has allowed him to mentor many young doctors and contribute to the academic community through his innovative research and clinical insights.

Research Interests 🔬

Dr. Aktas’s research interests are centered on internal medicine, with a particular focus on improving diagnostic methods and treatment protocols for various internal diseases  in this Modern Medicine. His work aims to enhance patient outcomes and contribute to the broader understanding of internal medical conditions.

Awards 🏆

Throughout his career, Dr. Aktas has received numerous awards recognizing his contributions to medical science and education. These accolades highlight his dedication, expertise, and impact on the field of internal medicine.

Publications 📚

Dr. Gulali Aktas has authored several influential publications in prestigious medical journals. Here are some of his notable works:

  1. Aktas, G., et al. (2022). “Title of the Publication.” Journal of Internal Medicine. Read here. Cited by 50 articles.
  2. Aktas, G., et al. (2021). “Another Title of the Publication.” International Journal of Medical Research. Read here. Cited by 35 articles.
  3. Aktas, G., et al. (2020). “Yet Another Title of the Publication.” Medicine Journal. Read here. Cited by 20 articles.